"Red Onion in Gestational diabetes mellitus"

The Effect of Oral Capsule of hydro-alcoholic Extract of Red Onion (Allium cepa) on Blood Glucose in Women with Gestational diabetes mellitus under Diet Therapy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200224046607N1

Enrollment

Registered

2020-03-29

Start date

2020-04-20

Completion date

Unknown

Last updated

2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Mellitus. Diabetes mellitus arising in pregnancy

Interventions

Intervention 1: Intervention group: Take the red onion extract capsule twice daily and in a 500 mg capsule half an hour after breakfast and lunch, with a 6 to 7 hour interval between meals and routine

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Iranian nationality and resident in Mashhad Has minimum literacy skills Written consent to participate in the study Phone number for urgent contact with yourself or family members Pregnant mother age between 18-35 years Single pregnancy Gestational age 30-24 weeks Gestational diabetes is confirmed by tests and a doctor Fasting blood glucose test and two hours postprandial (to confirm treatment of gestational diabetes with post-OGTT impairment) fasting blood glucose below 93 mg / dl and two hours postprandial blood glucose below 120 mg / dl and confirmation of gestational diabetes control With a diet by a gynecologist Fasting serum glucose levels below 92mg / dl at first pregnancy visit Normal outcome of fetal malformation screening tests and fetal anomaly ultrasound

Exclusion criteria

Exclusion criteria: Addiction to psychotropic substances, stimulants, alcohol, tobacco and opioids Having a medical condition Having midwifery problems Being a psychiatrist in the last 6 months and taking psychotropic drugs Allergy to onions or Lilias family members Preventive Speech and Behavioral Disorders Communication with Researcher

Design outcomes

Primary

Measure	Time frame
Fasting blood glucose. Timepoint: At baseline, 2 weeks and 4 weeks after intervention. Method of measurement: Intravenous Blood Test.;Blood glucose two hours after meals. Timepoint: At baseline, 2 weeks and 4 weeks after intervention. Method of measurement: Intravenous Blood Test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzaneh salajegheh

Mashhad University of Medical Sciences

salajeghehtf971@mums.ac.ir+98 51 3859 1511

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026